In-Vitro Biofilm Formation and Antimicrobial Resistance of Escherichia coli in Diabetic and Nondiabetic Patients

Table 5

Antimicrobial resistance of biofilm producing and nonproducing E. coli.

Antimicrobial agents	Biofilm producer E. coli ()		Biofilm nonproducer E. coli ()		-value
	Frequency	%	Frequency	%
Amikacin	9	12.3%	11	11.0%	0.787
Amoxicillin	68	93.2%	88	88.0%	0.261
Ciprofloxacin	55	75.3%	52	52.0%	0.002
Ceftriaxone	51	69.9%	46	46.0%	0.002
Cotrimoxazole	50	68.5%	52	52.0%	0.029
Nitrofurantoin	9	12.3%	12	12.0%	0.0948
Piperacillin–tazobactum	26	35.6%	32	32.0%	0.619
Imipenem	7	9.6%	6	6.0%	0.376
Tetracycilin	19	26.0%	32	32.0%	0.395

Bold value indicates the significance difference between the antimicrobial resistance pattern of biofilm producing and non-producing E. coli for respective antimicrobial agents.